Stocks Eli Lilly and Co

More

  • Stocks limp into the busiest day of the earnings season after throwing a tantrum over the Fed's cautious remarks about a slowing economy.

  • Leonard Schleifer

    Biotech CEOs say that drug pricing needs to be balanced enough to support research and development.

  • Novartis CEO, Joseph Jimenez (L), Pfizer CEO, Ian Read (C), and Eli Lilly & Co. CEO Dr. John Lechleiter (R).

    Several factors are being overlooked when discussing drug pricing in the U.S., three pharma CEOs say.

  • Rising interest rates and wobbly markets may roil some stocks, but experts believe these picks will profitably ride out the storm.

  • *First Solar up after Goldman upgrades stock to buy. After weak Chinese economic data drove stocks down sharply on Monday, the People's Bank of China on Tuesday injected $20 billion into the financial system in a bid to help its markets. Wal Mart Stores Inc shares, up 2.4 percent at $62.92, helped to lift both the Dow and S&P 500, though Monday's big selloff and...

  • *First Solar up after Goldman upgrades stock to buy. In a bid to stabilize its markets, the People's Bank of China on Tuesday injected $20 billion into the financial system. Gilead Sciences Inc rose 1.7 percent to $99.64, helping to lift the S&P 500, after its experimental hepatitis B drug was found safer than, yet as effective, as its approved treatment Viread.

  • *First Solar up after Goldman upgrades stock to buy. In a bid to stabilize its markets, the People's Bank of China on Tuesday injected $20 billion into the financial system. "Fears of a global recession are valid and fears about China are valid, and they will put some downward pressure on stocks in general, so I do expect 2016 to be negative, but not by much," said Mohannad...

  • *Sanofi and Mannkind terminate deal for Afrezza. LONDON, Jan 5- French drugmaker Sanofi is to stop selling an inhalable insulin developed by Mannkind, following disappointing sales of the product since its launch in February 2015. Rights to Afrezza will revert to Mannkind from Sanofi in the next 90 to 180 days and Mannkind said it was reviewing strategic options...

  • Jan 5- Eli Lilly and Co on Tuesday forecast 2016 revenue below expectations but said that its Jardiance diabetes treatment grabbed market share during the fourth quarter, which helped shares rise as much as 3 percent. Earlier on Tuesday, the company said in a news release that it expected revenue of $20.2 billion to $20.7 billion for 2016, below the average...

  • Traders work on the floor of the New York Stock Exchange.

    U.S. stock index futures pared losses to point to flat to higher open as oil struggled for gains amid pressure from jittery Chinese markets.

  • *Eli Lilly down after 2016 profit, rev forecast. *Dupont down after Citi downgrade. "I think everybody's finally getting settled back in and they're trying to assess really how global growth is going to impact their investments for the rest of the year," Kevin Kelly, CIO of Recon Capital Partners.

  • Traders work on the floor of the New York Stock Exchange.

    Some of the names on the move ahead of the open.

  • Lilly corporate headquarters in Indianapolis, Indiana

    Drugmaker Eli Lilly revised its 2015 earnings estimate lower and forecast 2016 earnings of $2.92 to $3.02 per share.

  • Jan 5- Eli Lilly and Co forecast 2016 earnings and revenue below analysts' expectations and the drugmaker estimated 2015 profit below its forecast, citing a charge related to a deal. Lilly said it expected revenue of $20.2 billion- $20.7 billion for 2016, below the average analyst estimate of $21.36 billion, according to Thomson Reuters I/B/E/S.

  • *The slide prompted a near- $20 billion injection by the People's Bank of China to stabilize markets. *Dupont's shares were down 1.5 percent at $62.10 in premarket trading after Citigroup cut its rating on the Dow component to "neutral." *Microsoft was down 0.8 percent at $54.38 as a Chinese regulator sought explanations from the software maker on findings from an...

  • U.S. stock futures were under pressure again this morning, after Monday's worst start of a new year for the S&P 500 since 2001.

  • Traders work on the floor of the New York Stock Exchange.

    U.S. stocks opened sharply lower in a global equities sell off that started with a report showing a tenth month of decline in Chinese manufacturing.

  • SHANGHAI, Dec 30- China Animal Healthcare, part owned by Eli Lilly and Co, said on Wednesday it was hunting for five years-worth of financial documents that were lost after the truck carrying them was stolen as the driver took a lunch break. China Animal Healthcare, whose shares have been suspended since March and which is in the middle of an investigation of its...

  • SHANGHAI, Dec 30- China Animal Healthcare, part owned by Eli Lilly and Co, said on Wednesday it was hunting for five years-worth of financial documents that were lost after the truck carrying them was stolen as the driver took a lunch break. China Animal Healthcare, whose shares have been suspended since March and which is in the middle of an investigation of its...

  • China Animal Healthcare has managed a first: losing five years of financial statements midway through a forensic audit ordered by regulators.